Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28435208 | 0.82 | CA1 (0.48) | CA1CA2 | |
| SCHEMBL19130433 | 0.79 | CA1 (0.43) | CA1CA2 | |
| SCHEMBL12247858 | 0.76 | CA2 (0.46) | CA1CA2 | |
| SCHEMBL18575562 | 0.75 | CA1 (0.46) | CA1CA2 | |
| SCHEMBL12247862 | 0.72 | CA1 (0.42) | CA1CA2 | |
| SCHEMBL29691004 | 0.72 | CA2 (0.42) | CA1CA2 | |
| SCHEMBL1725852 | 0.72 | CA2 (0.42) | CA1CA2 | |
| SCHEMBL12247859 | 0.72 | CA1 (0.42) | CA1CA2 | |
| SCHEMBL19149411 | 0.70 | — | — | |
| SCHEMBL19130431 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024043340-A1 | LITHIUM ION SECONDARY BATTERY | セントラル硝子株式会社 | 2024-02-29 | — | — | WO | disclosed |
| US-11171361-B2 | Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same | CENTRAL GLASS CO., LTD. (JP) | 2021-11-09 | — | — | US | disclosed |
| US-11145904-B2 | Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same | CENTRAL GLASS CO., LTD. (JP) | 2021-10-12 | — | — | US | disclosed |
| EP-3467928-B1 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTIC SOLUTION SECONDARY BATTERY | CENTRAL GLASS CO LTD (JP) | 2021-03-03 | — | — | EP | disclosed |
| EP-3598560-B1 | ELECTROLYTE SOLUTION FOR NON-AQUEOUS-ELECTROLYTE BATTERY, AND NON-AQUEOUS ELECTROLYTE BATTERY USING THE SAME | CENTRAL GLASS CO LTD (JP) | 2020-09-30 | — | — | EP | disclosed |
| US-20200136186-A1 | ELECTROLYTE SOLUTION FOR NON-AQUEOUS ELECTROLYTE BATTERY, AND NON-AQUEOUS ELECTROLYTE BATTERY USING THE SAME | CENTRAL GLASS CO., LTD. (JP) | 2020-04-30 | — | — | US | disclosed |
| US-20200119400-A1 | ELECTROLYTE SOLUTION FOR NON-AQUEOUS ELECTROLYTE BATTERY, AND NON-AQUEOUS ELECTROLYTE BATTERY USING THE SAME | CENTRAL GLASS CO., LTD. (JP) | 2020-04-16 | — | — | US | disclosed |
| US-10553904-B2 | Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same | CENTRAL GLASS CO., LTD. (JP) | 2020-02-04 | — | — | US | disclosed |
| EP-3261166-B1 | ELECTROLYTE FOR NONAQUEOUS-ELECTROLYTE CELL, AND NON-AQUEOUS ELECTROLYTE CELL IN WHICH SAME IS USED | CENTRAL GLASS CO LTD (JP) | 2019-11-20 | — | — | EP | disclosed |
| US-10424794-B2 | Ionic complex, electrolyte for nonaqueous electrolyte battery, nonaqueous electrolyte battery and ionic complex synthesis method | CENTRAL GLASS CO., LTD. (JP) | 2019-09-24 | — | — | US | disclosed |
| US-10211480-B2 | Electrolytic solution for non-aqueous electrolyte battery and non-aqueous electrolyte battery using the same | CENTRAL GLASS CO., LTD. (JP) | 2019-02-19 | — | — | US | disclosed |
| US-20180034103-A1 | ELECTROLYTE SOLUTION FOR NON-AQUEOUS ELECTROLYTE BATTERY, AND NON-AQUEOUS ELECTROLYTE BATTERY USING THE SAME | CENTRAL GLASS CO., LTD. (JP) | 2018-02-01 | — | — | US | disclosed |
| EP-3261166-A1 | ELECTROLYTE FOR NONAQUEOUS-ELECTROLYTE CELL, AND NON-AQUEOUS ELECTROLYTE CELL IN WHICH SAME IS USED | Central Glass Co., Ltd. (JP) | 2017-12-27 | — | — | EP | disclosed |
| US-20170331143-A1 | ELECTROLYTIC SOLUTION FOR NON-AQUEOUS ELECTROLYTE BATTERY AND NON-AQUEOUS ELECTROLYTE BATTERY USING THE SAME | CENTRAL GLASS CO., LTD. (JP) | 2017-11-16 | — | — | US | disclosed |
| US-20170204124-A1 | Ionic Complex, Electrolyte for Nonaqueous Electrolyte Battery, Nonaqueous Electrolyte Battery and Ionic Complex Synthesis Method | CENTRAL GLASS COMPANY, LIMITED (JP) | 2017-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11145904-B2 | Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same | ANO1, KCNN2, KCNN1 | CA1 134/4885CA2 225/4885 |
| US-20200119400-A1 | ELECTROLYTE SOLUTION FOR NON-AQUEOUS ELECTROLYTE BATTERY, AND NON-AQUEOUS ELECTROLYTE BATTERY USING THE SAME | KCNN1, KCNN2, ANO1 | CA1 146/4885CA2 464/4885 |
| US-20200136186-A1 | ELECTROLYTE SOLUTION FOR NON-AQUEOUS ELECTROLYTE BATTERY, AND NON-AQUEOUS ELECTROLYTE BATTERY USING THE SAME | ANO1, KCNN2, KCNN1 | CA1 134/4885CA2 225/4885 |
| US-20170204124-A1 | Ionic Complex, Electrolyte for Nonaqueous Electrolyte Battery, Nonaqueous Electrolyte Battery and Ionic Complex Synthesis Method | HCN2, KCNN4, KCNH3 | CA1 237/4885CA2 200/4885 |
| US-10553904-B2 | Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same | KCNN2, KCNN1, HCN2 | CA1 183/4885CA2 308/4885 |
| US-10424794-B2 | Ionic complex, electrolyte for nonaqueous electrolyte battery, nonaqueous electrolyte battery and ionic complex synthesis method | HCN2, KCNN4, KCNH3 | CA1 237/4885CA2 200/4885 |
| US-11171361-B2 | Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same | KCNN1, KCNN2, ANO1 | CA1 146/4885CA2 464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.